Form 4: NeueHealth Director Robert Sheehy Reports Stock Transactions
SEC Form 4 Filing
Director Robert Sheehy reports acquisition and disposal of NeueHealth, Inc. stock and restricted stock units.
Summary
- Robert Sheehy, a director of NeueHealth, Inc., filed a Form 4 detailing changes in beneficial ownership.
- On May 12, 2024, Sheehy acquired 4,755 shares of common stock.
- Also on May 12, 2024, Sheehy disposed of 4,755 shares of common stock.
- Sheehy indirectly owns 250,690 shares through the Robert J. Sheehy Revocable Trust.
- On May 13, 2024, Sheehy acquired 10,500 restricted stock units (RSUs), each representing a contingent right to receive one share of NeueHealth's common stock.
- These RSUs vest on May 13, 2025.
- Sheehy directly owns 10,500 derivative securities.
- Sheehy disposed of 4,755 restricted stock units on May 12, 2024.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by a company director, with neutral sentiment.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to the market.
Stakeholder Impact
- Shareholders are informed about the transactions of a key insider, which can influence investor sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/12/2024 | Acquisition and disposal of common stock and disposal of restricted stock units. |
| 05/13/2024 | Acquisition of restricted stock units. |
| 05/13/2025 | Vesting date for 10,500 restricted stock units. |
| 05/14/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.